Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis

Clin Infect Dis. 2002 Sep 15;35(6):650-8. doi: 10.1086/342059. Epub 2002 Aug 20.

Abstract

Of 250 consecutively admitted patients with central nervous system (CNS) infections who were treated during a 1-year period, all 133 patients with tickborne encephalitis (TBE) were included in a prospective follow-up study. TBE presented as mild (meningeal) in 43.6% of patients and as moderate or severe (encephalitic) in 43.6% and 12.8% of patients, respectively. Paralytic disease was observed in 3.8% of the subjects, and cranial nerve injury was observed in 5.3%. One patient died of TBE. Permanent CNS dysfunction after 1 year was found in 30.8% of patients; in 8.5% of all TBE cases, severe disabilities required adjustment of daily activities. Corticosteroid treatment did not seem to improve outcome. A progressive course of TBE was noted in 2 patients. The risk of incomplete recovery was significantly higher among patients with the encephalitic form of TBE (odds ratio, 4.066; 95% confidence interval, 1.848-8.947). In conclusion, TBE is an important pathogen in CNS infection in the Kaunas region of Lithuania, and it causes long-lasting morbidity in one-third of cases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aged
  • Encephalitis / cerebrospinal fluid
  • Encephalitis / diagnosis
  • Encephalitis / drug therapy
  • Encephalitis / epidemiology*
  • Endemic Diseases*
  • Female
  • Humans
  • Lithuania / epidemiology
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Prognosis
  • Severity of Illness Index
  • Surveys and Questionnaires
  • Tick-Borne Diseases / cerebrospinal fluid
  • Tick-Borne Diseases / diagnosis
  • Tick-Borne Diseases / drug therapy
  • Tick-Borne Diseases / epidemiology*

Substances

  • Adrenal Cortex Hormones